Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
national top stories
roche
5
×
san francisco top stories
5
×
biotech
boston blog main
boston top stories
clinical trials
fda
san francisco blog main
blueprint medicines
cancer
genentech
indiana blog main
indiana top stories
national
new york top stories
avapritinib
boston
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
drug prices
drugs
eli lilly
europe top stories
gene therapy
investing
medullary thyroid cancer
new york blog main
non-small cell lung cancer
novartis
pralsetinib
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
What
fda
5
×
drug
cancer
approval
approved
blueprint
genetic
medicine
medicines
new
ret
roche
therapy
address
ahead
approves
asco
atrophy
bio
branded
candidate
carries
certain
choices
commissioner
consumers
costly
counterweight
currently
daily
deeper
designed
dna
drugs
elevatebio
evrysdi
fingerprint
friday
generic
going
Language
unset
Current search:
roche
×
fda
×
" san francisco top stories "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues